Related references
Note: Only part of the references are listed.Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults
Beth Han et al.
JAMA PSYCHIATRY (2021)
Effects of an Adenosine A2A Receptor Antagonist on Striatal Dopamine D2-Type Receptor Availability: A Randomized Control Study Using Positron Emission Tomography
Kyoji Okita et al.
FRONTIERS IN NEUROSCIENCE (2021)
The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson's disease
Jiang-Fan Chen et al.
PURINERGIC SIGNALLING (2020)
Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder A Review
Martin P. Paulus et al.
JAMA PSYCHIATRY (2020)
No significant elevation of translocator protein binding in the brains of recently abstinent methamphetamine users
Edythe D. London et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Methamphetamine-Induced Neuronal Damage: Neurotoxicity and Neuroinflammation
Buyun Kim et al.
BIOMOLECULES & THERAPEUTICS (2020)
Neuroinflammation in psychiatric disorders: PET imaging and promising new targets
Jeffrey H. Meyer et al.
LANCET PSYCHIATRY (2020)
Inactivation of endothelial adenosine A2A receptors protects mice from cerebral ischaemia-induced brain injury
Yaqi Zhou et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Methamphetamine Use and Cardiovascular Disease In Search of Answers
Christopher G. Kevil et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
THE NEUROSCIENCE OF DRUG REWARD AND ADDICTION
Nora D. Volkow et al.
PHYSIOLOGICAL REVIEWS (2019)
Dopamine and addiction: what have we learned from 40 years of research
Marcello Solinas et al.
JOURNAL OF NEURAL TRANSMISSION (2019)
Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users
K. Okita et al.
MOLECULAR PSYCHIATRY (2018)
Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users
Scott J. Moeller et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Inhibition of astrocytic adenosine receptor A2A attenuates microglial activation in a mouse model of Sandhoff disease
Yasuhiro Ogawa et al.
NEUROBIOLOGY OF DISEASE (2018)
Methamphetamine neurotoxicity, microglia, and neuroinflammation
Fatemeh Shaerzadeh et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Effect of overnight smoking abstinence on a marker for microglial activation: a [11C]DAA1106 positron emission tomography study
Arthur L. Brody et al.
PSYCHOPHARMACOLOGY (2018)
Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia
Manabu Kubota et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
Stroke and methamphetamine use in young adults: a review
Julia M. Lappin et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [11C]DAA1106 Positron Emission Tomography Study
Arthur L. Brody et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine A Systematic Review and Meta-analysis
Abhishekh H. Ashok et al.
JAMA PSYCHIATRY (2017)
Visualization of ligand-induced dopamine D2S and D2L receptor internalization by TIRF microscopy
Alina Tabor et al.
SCIENTIFIC REPORTS (2017)
Prevalence and nature of cardiovascular disease in methamphetamine-related death: A national study
Shane Darke et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals
Kyoji Okita et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment
Chelsea L. Robertson et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Allosteric mechanisms within the adenosine A2A -dopamine D2 receptor heterotetramer
Sergi Ferre et al.
NEUROPHARMACOLOGY (2016)
Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging
Edythe D. London et al.
BRAIN RESEARCH (2015)
A Long-Term Study of Istradefylline Safety and Efficacy in Patients With Parkinson Disease
Tomoyoshi Kondo et al.
CLINICAL NEUROPHARMACOLOGY (2015)
Long-term test-retest reliability of striatal and extrastriatal dopamine D2/3 receptor binding: study with [11C]raclopride and high-resolution PET
Kati Alakurtti et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
The dopamine theory of addiction: 40 years of highs and lows
David J. Nutt et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain
N. D. Volkow et al.
TRANSLATIONAL PSYCHIATRY (2015)
Performance measurement of PSF modeling reconstruction (True X) on Siemens Biograph TruePoint TrueV PET/CT
Young Sub Lee et al.
ANNALS OF NUCLEAR MEDICINE (2014)
Dopamine and glucose, obesity, and reward deficiency syndrome
Kenneth Blum et al.
FRONTIERS IN PSYCHOLOGY (2014)
Modulation of A2a receptor antagonist on D2 receptor internalization and ERK phosphorylation
Li Huang et al.
ACTA PHARMACOLOGICA SINICA (2013)
Istradefylline: First Global Approval
Rosselle Dungo et al.
DRUGS (2013)
Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications
Christopher D. Verrico et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Effects of the Youth Empowerment Seminar on Impulsive Behavior in Adolescents
Dara G. Ghahremani et al.
JOURNAL OF ADOLESCENT HEALTH (2013)
Effects of Adenosine Receptor Antagonists on the In Vivo LPS-Induced Inflammation Model of Parkinson's Disease
Krystyna Golembiowska et al.
NEUROTOXICITY RESEARCH (2013)
Decreased dopamine activity predicts relapse in methamphetamine abusers
G. J. Wang et al.
MOLECULAR PSYCHIATRY (2012)
Imaging brain response to reward in addictive disorders
Daniel W. Hommer et al.
ADDICTION REVIEWS (2011)
Neural Correlates of Affect Processing and Aggression in Methamphetamine Dependence
Doris E. Payer et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
A Bayesian model of shape and appearance for subcortical brain segmentation
Brian Patenaude et al.
NEUROIMAGE (2011)
Addiction: Decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit
Nora D. Volkow et al.
BIOESSAYS (2010)
Caffeine and Adenosine
Joaquim A. Ribeiro et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Imaging dopamine's role in drug abuse and addiction
N. D. Volkow et al.
NEUROPHARMACOLOGY (2009)
The Role of Oxidative Stress, Metabolic Compromise, and Inflammation in Neuronal Injury Produced by Amphetamine-Related Drugs of Abuse
Bryan K. Yamamoto et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2008)
The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders
Sriram Venneti et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Methamphetamine causes microglial activation in the brains of human abusers
Yoshimoto Sekine et al.
JOURNAL OF NEUROSCIENCE (2008)
Development and validation of the Stimulant Relapse Risk Scale for drug abusers in Japan
Yasukazu Ogai et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
Methamphetamine use and infectious disease-related behaviors in men who have sex with men: implications for interventions
Steven Shoptaw et al.
ADDICTION (2007)
Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone formation-related molecules
I Miyazaki et al.
FASEB JOURNAL (2006)
Dopamine responsiveness is regulated by targeted sorting of D2 receptors
SE Bartlett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse
M Pierri et al.
NEUROPHARMACOLOGY (2005)
Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET:: An imaging tool for glial cells in the brain
J Maeda et al.
SYNAPSE (2004)
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications
ND Volkow et al.
MOLECULAR PSYCHIATRY (2004)
Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors
J Hillion et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)